Wird geladen...
Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia
BACKGROUND: This post hoc analysis of clinical trial data evaluated long-term, self-reported mental and physical health-related quality of life (HRQoL) scores in schizophrenia patients receiving aripiprazole lauroxil (AL), an atypical long-acting injectable (LAI) antipsychotic approved for the treat...
Gespeichert in:
| Veröffentlicht in: | BMC Psychiatry |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7992347/ https://ncbi.nlm.nih.gov/pubmed/33761928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-021-03124-2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|